Financings in Brief: Xomed Surgical Products
This article was originally published in The Gray Sheet
Executive Summary
Xomed Surgical Products: Plans to go public via an initial public offering of 2.5 mil. shares at $19-21 each. The Jacksonville, Florida-based company has filed a registration statement with the Securities and Exchange Commission for the offering, which is "expected to occur in mid-October," the firm says. Xomed produces microendoscopy instruments, implantable devices, nerve monitoring systems and disposable fluid-control products for the earn, nose and throat surgery market. Alex. Brown & Sons and UBS Securities are underwriters for the offering...